News

Filter

Current filters:

GenentechRegeneron

Roche unit in partial patent deal with Regeneron over Eylea; new indication for Avastin

04-01-2012

Regeneron Pharmaceuticals (Nasdaq: REGN) says it has entered into a non-exclusive license and partial…

AvastinBiotechnologyEuropeEyleaGenentechLegalNorth AmericaOncologyOphthalmicsPatentsPharmaceuticalRegeneronRegulationRoche

COMPANY SPOTLIGHT

Menarini

Back to top